Expert of the Month Interviews
Gene Therapy in Hemophilia experts from around the world provide updates monthly on the latest information and news.
This Month's Video: Spark Phase 1/2 SPK-8011 Clinical Trial
Presented by: Stacy E. Croteau, MD, MMS Medical Director, Boston Hemophilia Center Assistant Professor of Pediatrics, Harvard Medical School Boston, Massachusetts
Additional Updates
Five Year Data Confirms Stable FIX Expression
Presented by: Wolfgang A. Miesbach, MD, PhD, Department of Coagulation Disorders and the Comprehensive Care Haemophilia Centre, Goethe University Hospital, Frankfurt/Main Germany.
What to Expect at the upcoming ISTH Congress in Gene Therapy Hemophilia
Presented by: David Lillicrap, MD, FRCPC, Department of Pathology & Molecular Medicine, Queen's University, Kingston, Ontario
Highlights from the ASGCT 24th Annual Meeting
Presented by: Wolfgang A. Miesbach, MD, PhD, Department of Coagulation Disorders and the Comprehensive Care Haemophilia Centre, Goethe University Hospital, Frankfurt/Main Germany.
Hepatoxicity and Gene Therapy
Presented by: Guy Young, MD, Director, Hemostasis and Thrombosis Program, Professor of Pediatrics (Clinical Scholar), Keck School of Medicine of USC, Los Angeles, California.
Durability: Factor VIII and Factor IX Differences
Presented by: Guy Young, MD, Director, Hemostasis and Thrombosis Program, Professor of Pediatrics (Clinical Scholar), Keck School of Medicine of USC, Los Angeles, California.